GlassScriptPhysician profile
Jane D Allen
NPI 1225083843
$1,504.80
in general payments reported to CMS, 2019-2025
22 companies · $307 in 2025
The $307 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $314 · 2020: $246 · 2021: $99.25 · 2022: $132 · 2023: $175 · 2024: $231 · 2025: $307.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $713.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $713.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $239.70 | 2019-2023 | Orilissa, Lo Loestrin Fe |
| Sumitomo Pharma America, INC. | $189.90 | 2023-2025 | Myfembree |
| Amag Pharmaceuticals, INC. | $145.32 | 2019 | |
| Therapeuticsmd, INC. | $139.88 | 2019-2022 | |
| Astellas Pharma US INC | $112.60 | 2024-2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $103.41 | 2019-2025 | |
| Daiichi Sankyo INC. | $71.63 | 2020-2024 | Injectafer |
| Mayne Pharma Commercial LLC | $65.75 | 2023-2025 | |
| Dysis Medical, INC. | $57.21 | 2020 | |
| Hologic Sales and Service, LLC | $53.21 | 2019-2021 | |
| Mylan Pharmaceuticals INC. | $52.36 | 2020-2021 | |
| Sage Therapeutics, LLC | $48.54 | 2024-2025 | Zurzuvae |
| Coopersurgical, INC. | $47.06 | 2022-2024 | Paragard T 380a |
| Exeltis, USA INC. | $40.22 | 2023-2025 | Slynd |
| Dexcom, INC. | $27.99 | 2025 | Dexcom G6 Transmitter |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $23.19 | 2025 | The Cologuard Plus Collection Kit |
| Aspira Women'S Health INC | $20.75 | 2024 | Ova1 |
| Hologic INC | $19.63 | 2021 | |
| Organon LLC | $18.77 | 2022 | |
| Agile Therapeutics, INC. | $16.13 | 2021 | |
| Avion Pharmaceuticals | $11.55 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jane Allen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.